BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32380077)

  • 21. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
    Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
    Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
    Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-κB axis: Shedding new light on resistance to Aprepitant.
    Bashash D; Safaroghli-Azar A; Bayati S; Razani E; Pourbagheri-Sigaroodi A; Gharehbaghian A; Momeny M; Sanjadi M; Rezaie-Tavirani M; Ghaffari SH
    Int J Biochem Cell Biol; 2018 Oct; 103():105-114. PubMed ID: 30145367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-
    Ghahremanloo A; Javid H; Afshari AR; Hashemy SI
    Biomed Res Int; 2021; 2021():1383878. PubMed ID: 34395609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hsa-miR-5582-3P regulatory effect on TGFβ signaling through targeting of TGFβ-R1, TGFβ-R2, SMAD3, and SMAD4 transcripts.
    Abedini Bakhshmand E; Mohammad Soltani B; Fasihi A; Mowla SJ
    J Cell Biochem; 2018 Dec; 119(12):9921-9930. PubMed ID: 30129155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockdown of Rab7a suppresses the proliferation, migration, and xenograft tumor growth of breast cancer cells.
    Xie J; Yan Y; Liu F; Kang H; Xu F; Xiao W; Wang H; Wang Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 29769411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis.
    Wu Y; Yu X; Yi X; Wu K; Dwabe S; Atefi M; Elshimali Y; Kemp KT; Bhat K; Haro J; Sarkissyan M; Vadgama JV
    Cancer Res; 2017 Mar; 77(6):1383-1394. PubMed ID: 28115363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.
    Zhou Y; Wang M; Tong Y; Liu X; Zhang L; Dong D; Shao J; Zhou Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819875168. PubMed ID: 31506061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
    Sun FD; Wang PC; Luan RL; Zou SH; Du X
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.
    AlHossiny M; Luo L; Frazier WR; Steiner N; Gusev Y; Kallakury B; Glasgow E; Creswell K; Madhavan S; Kumar R; Upadhyay G
    Cancer Res; 2016 Jun; 76(11):3376-86. PubMed ID: 27197181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coactosin-like protein CLP/Cotl1 suppresses breast cancer growth through activation of IL-24/PERP and inhibition of non-canonical TGFβ signaling.
    Xia L; Xiao X; Liu WL; Song Y; Liu TJJ; Li YJ; Zacksenhaus E; Hao XJ; Ben-David Y
    Oncogene; 2018 Jan; 37(3):323-331. PubMed ID: 28925397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ZIC1 acts a tumor suppressor in breast cancer by targeting survivin.
    Han W; Cao F; Gao XJ; Wang HB; Chen F; Cai SJ; Zhang C; Hu YW; Ma J; Gu X; Ding HZ
    Int J Oncol; 2018 Sep; 53(3):937-948. PubMed ID: 29956756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteasomes reactivator REG gamma enchances oncogenicity of MDA-MB-231 cell line via promoting cell proliferation and inhibiting apoptosis.
    Tian M; Xiaoyi W; Xiaotao L; Guosheng R
    Cell Mol Biol (Noisy-le-grand); 2009 Jun; 55 Suppl():OL1121-31. PubMed ID: 19656465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.
    Ilmer M; Garnier A; Vykoukal J; Alt E; von Schweinitz D; Kappler R; Berger M
    Mol Cancer Ther; 2015 Dec; 14(12):2712-21. PubMed ID: 26516161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.
    Chen CS; Lee CH; Hsieh CD; Ho CT; Pan MH; Huang CS; Tu SH; Wang YJ; Chen LC; Chang YJ; Wei PL; Yang YY; Wu CH; Ho YS
    Breast Cancer Res Treat; 2011 Jan; 125(1):73-87. PubMed ID: 20229177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AMBRA1 Promotes TGFβ Signaling via Nonproteolytic Polyubiquitylation of Smad4.
    Liu J; Yuan B; Cao J; Luo H; Gu S; Zhang M; Ding R; Zhang L; Zhou F; Hung MC; Xu P; Lin X; Jin J; Feng XH
    Cancer Res; 2021 Oct; 81(19):5007-5020. PubMed ID: 34362797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.
    Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Pandey R; Funk JL
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.
    Meng D; Yu Q; Feng L; Luo M; Shao S; Huang S; Wang G; Jing X; Tong Z; Zhao X; Liu R
    Clin Transl Oncol; 2019 Jul; 21(7):910-923. PubMed ID: 30565087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4.
    Yang L; Hu S; Tan J; Zhang X; Yuan W; Wang Q; Xu L; Liu J; Liu Z; Jia Y; Huang X
    Oncotarget; 2016 Sep; 7(38):61562-61574. PubMed ID: 27528036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.